Search results
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 hours agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...
Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
Yahoo Finance· 3 hours agoJørgensen said he doesn't like the term "junk patents" and believes the company is ethical about its...
Novo Nordisk Lifts Guidance as Blockbuster Drug Demand Shows No Signs of Abating — Update
Morningstar· 13 hours agoSales in the first quarter were boosted by adjustments to gross-to-net rebates in the U.S.--the discount offered between the list price and the actual net sales price--related ...
‘Lifesaving medication’: Bill aims to cut prescription drug prices for seniors
Las Vegas Review-Journal· 1 day agoIf a senior has a 50 percent coinsurance and their medication’s list price is $200, they pay $100...
Here's Why Eli Lilly Stock Remains a Screaming Buy
Motley Fool via Yahoo Finance· 10 hours agoIt also resubmitted for FDA approval of the drug in treating atopic dermatitis following a complete response letter from the agency due to issues with a...
JD Supra: Every Little One, Every Little One: FDA Issues a Warning Letter to a Medical Device...
JD Supra· 38 minutes agoKiss,” comes to mind when we read a recent Food and Drug Administration Warning Letter issued to a reprocessor and...Warning Letter mentioned quality-related concerns, the ...
Rosen introduces bill to lower prescription drug costs for seniors
Las Vegas Review-Journal· 1 day agoFor instance, if a senior has a 50 percent coinsurance and their medication’s list price is $200,...
Lawsuit accuses Boehringer Ingelheim of false patent listings
Hartford Business Journal· 6 hours agoThe lawsuit, first reported by law.com, seeks class action status...are Boehringer Ingelheim...
Novo Nordisk Investing $6 Billion to Increase Access to Ozempic and Wegovy amid Nationwide Shortage
People Magazine· 3 hours agoNovo Nordisk is investing $6.5 billion to increase production of Ozempic and Wegovy. The...
Will the DEA reclassify marijuana as a Schedule III drug? What change means for Oklahoma
Gannett via AOL· 7 hours agoHere's what we know: DEA to reclassify marijuana as Schedule III drug USA Today recently reported that the Biden administration plans to remove marijuana from the
